UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

SLAS discovery, 2022-01, Vol.27 (1), p.68-76

2022

Link zum Volltext

Verfügbarkeit prüfen

BIOM-45. DETERMINANTS OF GBM VULNERABILITY TO INHIBITORS OF NEDD8 ACTIVATING ENZYME (NAE)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii14-vii14

2022

Link zum Volltext

Verfügbarkeit prüfen

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Genome medicine, 2014-01, Vol.6 (1), p.9-9, Article 9

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3681: Selective vulnerability of GBM PDX to a panel of EGFR tyrosine kinase inhibitors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3681-3681

2020

Link zum Volltext

Verfügbarkeit prüfen

BIOM-27. CELL-FREE DNA-BASED LIQUID BIOPSIES FOR THE REAL-TIME TRACKING OF TUMOR BURDEN AND TREATMENT RESPONSE IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v10-v10

2023

Link zum Volltext

Verfügbarkeit prüfen

DIPG-47. DISCOVERING A MOLECULAR BASIS FOR VULNERABILITY OF H3K27M-DMG TO HISTONE DEACETYLASE INHIBITORS

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i24-i24

2023

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of Myo1c (Myosin-IÎ²) Lipid Binding and Dissociation

The Journal of biological chemistry, 2002-11, Vol.277 (45), p.42763-42768

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2984: Building an in vitro blood brain barrier model to test the influence of tight junction gene alleles on disruption by focused ultrasound to treat brain tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2984-2984

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 318: Multi-omics to edge into precision medicine for DIPG

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.318-318

2021

Link zum Volltext

Verfügbarkeit prüfen

The Kinetic Mechanism of Myo1e (Human Myosin-IC)

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21514-21521

2002

Link zum Volltext

Verfügbarkeit prüfen

CSIG-31. MULTI-OMICS TO EDGE INTO PRECISION MEDICINE FOR DIPG

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi40-vi40

2021

Link zum Volltext

Verfügbarkeit prüfen

EXTH-17. A FOCUSED ULTRASOUND BLOOD BRAIN BARRIER DISRUPTION MODEL TO TEST THE INFLUENCE OF TIGHT JUNCTION GENES TO TREAT BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi167-vi167

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 180: Identifying signatures of vulnerability through machine learning in an umbrella trial for glioblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.180-180

2021

Link zum Volltext

Verfügbarkeit prüfen

BIOM-37. EXTRACELLULAR VESICLES AS A PHARMACODYNAMIC REPORTER IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v12-v12

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2189: Evaluating efficacy of repurposed drugs in treatment of glioblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2189-2189

2019

Link zum Volltext

Verfügbarkeit prüfen

BIOM-24. IDENTIFYING VULNERABILITY SIGNATURES THROUGH MACHINE LEARNING IN AN UMBRELLA TRIAL FOR GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii6-ii7

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5822: Targeting an immortalization mutation to control glioblastoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5822-5822

2020

Link zum Volltext

Verfügbarkeit prüfen

Establishing an Infrastructure for High-Throughput Short-Interfering RNA Screening

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1470, p.1

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract A142: Drug combination screen to identify novel synergy with Minnelide

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.A142-A142

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1434: Loss of PTEN confers resistance to neddylation inhibition through TOP2A in glioblastoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1434-1434

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2534: Underlying mechanism of response to neddylation inhibition in a subset of glioblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2534-2534

2021

Link zum Volltext

Verfügbarkeit prüfen

Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1857-1868

2022

Link zum Volltext

Verfügbarkeit prüfen

PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1857-1868

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1601: Potentiation of arsenic trioxide in glioblastoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1601-1601

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)
Tagungsberichte
(2)

Sprache

Englisch
(46)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(10)
Humans
(7)
Animals
(5)
Biochemistry & Molecular Biology
(5)
Cell Biology
(4)
Cell Line, Tumor
(3)
Genetics & Heredity
(3)
Kinetics
(3)
Myosin Type I - Chemistry
(3)
Technology
(3)
Actins - Metabolism
(2)
Amino Acid Motifs
(2)
Biochemical Research Methods
(2)
Calmodulin - Metabolism
(2)
Cancer
(2)
Chemistry
(2)
Computer Science
(2)
Computer Science, Artificial Intelligence
(2)
Genetic Aspects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

BIOM-45. DETERMINANTS OF GBM VULNERABILITY TO INHIBITORS OF NEDD8 ACTIVATING ENZYME (NAE)

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Abstract 3681: Selective vulnerability of GBM PDX to a panel of EGFR tyrosine kinase inhibitors

BIOM-27. CELL-FREE DNA-BASED LIQUID BIOPSIES FOR THE REAL-TIME TRACKING OF TUMOR BURDEN AND TREATMENT RESPONSE IN GLIOBLASTOMA

DIPG-47. DISCOVERING A MOLECULAR BASIS FOR VULNERABILITY OF H3K27M-DMG TO HISTONE DEACETYLASE INHIBITORS

Dynamics of Myo1c (Myosin-IÎ²) Lipid Binding and Dissociation

Abstract 2984: Building an in vitro blood brain barrier model to test the influence of tight junction gene alleles on disruption by focused ultrasound to treat brain tumors

Abstract 318: Multi-omics to edge into precision medicine for DIPG

The Kinetic Mechanism of Myo1e (Human Myosin-IC)

CSIG-31. MULTI-OMICS TO EDGE INTO PRECISION MEDICINE FOR DIPG

EXTH-17. A FOCUSED ULTRASOUND BLOOD BRAIN BARRIER DISRUPTION MODEL TO TEST THE INFLUENCE OF TIGHT JUNCTION GENES TO TREAT BRAIN TUMORS

Abstract 180: Identifying signatures of vulnerability through machine learning in an umbrella trial for glioblastoma

BIOM-37. EXTRACELLULAR VESICLES AS A PHARMACODYNAMIC REPORTER IN GLIOBLASTOMA

Abstract 2189: Evaluating efficacy of repurposed drugs in treatment of glioblastoma

BIOM-24. IDENTIFYING VULNERABILITY SIGNATURES THROUGH MACHINE LEARNING IN AN UMBRELLA TRIAL FOR GLIOBLASTOMA

Abstract 5822: Targeting an immortalization mutation to control glioblastoma

Establishing an Infrastructure for High-Throughput Short-Interfering RNA Screening

Abstract A142: Drug combination screen to identify novel synergy with Minnelide

Abstract 1434: Loss of PTEN confers resistance to neddylation inhibition through TOP2A in glioblastoma

Abstract 2534: Underlying mechanism of response to neddylation inhibition in a subset of glioblastoma

Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors

Abstract 1601: Potentiation of arsenic trioxide in glioblastoma

Aktive Filter

Suchergebnisse filtern